23.09.2021
An article from the 'Märkische Allgemeine' reports on companies from Brandenburg, which develop therapeutics and diagnostics for COVID-19.
The CRP apheresis as COVID-19 therapy, predominantly used in the Berlin clinic Havelhöhe, was described in this context.
The article can be read in German here.
